Skip to main content
Clinical Trials/NCT05553080
NCT05553080
Completed
Not Applicable

Significance of Immunohistochemical Expression of Fascin-1 in Colorectal Carcinoma

Sohag University2 sites in 1 country60 target enrollmentJanuary 1, 2022
ConditionsCancer of Colon

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer of Colon
Sponsor
Sohag University
Enrollment
60
Locations
2
Primary Endpoint
Evaluation of immunohistochemical staining of colorectal carcinoma by Fascin-1
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Colorectal carcinoma is a major health problem. As a malignant tumor, the malignant potential of colorectal carcinoma is based mainly on its ability to metastasis to different sites. Fascin-1 is an actin binding protein which is involved in reconstruction of intracellular actin network, the latter enforces the neoplastic cell to invade surrounding structures.

Detailed Description

colorectal carcinoma is an aggressive malignant tumor. It has high incidence of cancer-related morbidity and mortality. the malignant potential of a given neoplasm is based mainly on its ability to invade the surrounding vasculature and reach to distant sites, the latter is called metastasis. in order to metastasize to distant sites, the neoplastic cells must re-arrange the intracellular actin filaments into well formed intracellular assembly which enable the neoplastic cells to reach to distant sites. Fascin-1 is an actin binding protein, it is involved in reconstruction of actin assembly. fortunately, Fascin-1 could be blocked by newly developed medications, blocking of Fascin-1 may limit the metastasis of colorectal carcinoma. in current study the investigators detect Fascin-1 in colorectal carcinoma by immunohistochemical approach, then they correlated different levels of Fascin-1 expression to tumor clinical and pathological criteria as patients' ages, sexes, tumor stages, nodal metastasis, vascular and per-ineural invasions.

Registry
clinicaltrials.gov
Start Date
January 1, 2022
End Date
December 1, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Maisa Hashem Mohammed

Lecturer of Pathology

Sohag University

Eligibility Criteria

Inclusion Criteria

  • All cases of colorectal carcinoma.

Exclusion Criteria

  • cases diagnosed on basis of lower endoscopic biopsies or local resections without radical colectomy.
  • Patients with preopoerative history of chemo or radiotherapy.
  • Patients with poor clinical data.

Outcomes

Primary Outcomes

Evaluation of immunohistochemical staining of colorectal carcinoma by Fascin-1

Time Frame: September , 2022

correlation of different levels of Fascin-1 expression to patients' ages, sexes, tumor stage, nodal metastasis, vascular and perineural invasion.

Study Sites (2)

Loading locations...

Similar Trials